[Effectiveness of bioparox treatment in acute inflammatory diseases of the upper airways].
Acute inflammation of the upper respiratory tract was treated with bioparox in 40 patients and conventionally in 20 patients. The assessment of the treatment effect was carried out by subjective and objective responses, rhinomanometry, trends in cell composition and phagocytic activity of leukocytes in smears from nasal mucosa. The data obtained provided evidence for high efficacy of bioparox which promoted faster regress of subjective and objective manifestations of the inflammation.
Luchikhin
L A
LA
Buianovskaia
O A
OA
Derevianko
S N
SN
Paukova
M V
MV
D000208:Acute Disease; D000328:Adult; D000336:Aerosols / Q000008:administration & dosage / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D047630:Depsipeptides; D004724:Endoscopy; D005260:Female; D005670:Fusarium; D006801:Humans; D007827:Laryngitis / Q000175:diagnosis / Q000188:drug therapy; D008297:Male; D010612:Pharyngitis / Q000175:diagnosis / Q000188:drug therapy; D012141:Respiratory Tract Infections / Q000175:diagnosis / Q000188:drug therapy*; D012220:Rhinitis / Q000175:diagnosis / Q000188:drug therapy; D012852:Sinusitis / Q000175:diagnosis / Q000188:drug therapy; D013997:Time Factors
D000336:Aerosols; D000900:Anti-Bacterial Agents; D047630:Depsipeptides; C014001:fusafungin
Effektivnost' lecheniia bioparoksom ostrykh vospalitel'nykh zabolevaniĭ verkhnikh dykhatel'nykh puteĭ.